MilliporeSigma Articles

  1. Viral Vectors: Are We There Yet?

    What must we do as an industry to continue the momentum of cell and gene therapies and ensure these revolutionary treatments become a reality for patients who need them?

  2. Anticipating The Next Decade Of Gene Therapy

    The next decade will bring improvements including the development of alternative approaches to gene delivery, and advances in upstream and downstream processing, analytical methods and intensified/continuous processing.

  3. Viral Clearance Considerations For Adeno-Associated Virus (AAV) Vectors

    There is no one-size-fits-all model for AAV gene therapy products when it comes to viral clearance studies. Here, we address some of the questions concerning viral clearance studies for AAV vectors.